By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich said after the close of the market Tuesday that it has completed the acquisition of BioReliance Holdings for $350 million in cash.

It purchased the firm from Avista Capital Partners, which had acquired BioReliance nearly five years ago from Invitrogen, now part of Life Technologies, for $210 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.